1-1 of 1
Enxu Zhao
Close
Sort by
Journal Articles

A Phase 1, First-in-Human, Dose-Escalation Study of MGD024, a CD123 x CD3 Bispecific Dart® Molecule, in Patients with Relapsed or Refractory CD123-Positive (+) Hematologic Malignancies

Eric S. Winer, Michael Maris, Manish R. Sharma, Patrick Kaminker, Enxu Zhao, Ashley Ward, Andrew L. Sochacki
Journal: Blood
Blood (2022) 140 (Supplement 1): 11753–11754.
https://doi.org/10.1182/blood-2022-159524
Published: 2022